Novo Nordisk has questioned the FDA to block production of compounded copies of copyright, arguing that it’s too challenging to do safely. It’s the latest escalation in a very brewing war in between pharmaceutical firms and compounders.The Affiliated Push can be an impartial worldwide news Firm focused on factual reporting. Founded in 1846, AP